Source:http://linkedlifedata.com/resource/pubmed/id/17456248
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006935,
umls-concept:C0008318,
umls-concept:C0016157,
umls-concept:C0086045,
umls-concept:C0229671,
umls-concept:C0238598,
umls-concept:C0332173,
umls-concept:C0442027,
umls-concept:C0442805,
umls-concept:C0535968,
umls-concept:C0978787,
umls-concept:C1442465,
umls-concept:C1512806,
umls-concept:C1707455
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-8-20
|
pubmed:abstractText |
Many types of vitamin supplements are available on the market, but little is known about whether cholecalciferol obtained from fat-containing capsules differs in bioavailability from that of solid tablets. Our objective was to test whether 4 weeks of daily supplementation with 10 mug cholecalciferol given as a fish oil capsule produces a larger increase in serum 25-hydroxyvitamin D (s-25(OH)D) concentration compared with the same dose of cholecalciferol given as a multivitamin tablet. A total of seventy-four healthy subjects aged 19-49 years were initially included and fifty-five of these completed the study and fulfilled the inclusion criteria. After completing a self-administered questionnaire about diet and sunshine exposure and having a non-fasting venous blood sample drawn, participants were randomised to receive daily multivitamin tablets (n 28) or fish oil capsules (n 27), each containing equal doses of cholecalciferol. A second blood sample was drawn after 28 d. Mean baseline s-25(OH)D was 40.3 (sd 22.0) nmol/l in the multivitamin group and 48.5 (24.8) nmol/l in the fish oil group. When controlling for baseline s-25(OH)D, mean 4-week increase in s-25(OH)D was 35.8 (95 % CI 30.9, 40.8) nmol/l in the multivitamin group and 32.3 (95 % CI 27.3, 37.4) nmol/l in the fish oil group; the mean difference was 3.5 (95 % CI - 3.6, 10.6) nmol/l (P = 0.33). The results were unaltered by statistical adjustment for BMI, ethnic background, age and sex. We conclude that fish oil capsules and multivitamin tablets containing 10 microg cholecalciferol administered over a 4-week period produced a similar mean increase in s-25(OH)D concentration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/25-hydroxyvitamin D,
http://linkedlifedata.com/resource/pubmed/chemical/Capsules,
http://linkedlifedata.com/resource/pubmed/chemical/Cholecalciferol,
http://linkedlifedata.com/resource/pubmed/chemical/Fish Oils,
http://linkedlifedata.com/resource/pubmed/chemical/Tablets,
http://linkedlifedata.com/resource/pubmed/chemical/Vitamin D,
http://linkedlifedata.com/resource/pubmed/chemical/Vitamins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-1145
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
620-5
|
pubmed:meshHeading |
pubmed-meshheading:17456248-Administration, Oral,
pubmed-meshheading:17456248-Adult,
pubmed-meshheading:17456248-Biological Availability,
pubmed-meshheading:17456248-Capsules,
pubmed-meshheading:17456248-Cholecalciferol,
pubmed-meshheading:17456248-Dietary Supplements,
pubmed-meshheading:17456248-Female,
pubmed-meshheading:17456248-Fish Oils,
pubmed-meshheading:17456248-Humans,
pubmed-meshheading:17456248-Male,
pubmed-meshheading:17456248-Middle Aged,
pubmed-meshheading:17456248-Tablets,
pubmed-meshheading:17456248-Vitamin D,
pubmed-meshheading:17456248-Vitamins
|
pubmed:year |
2007
|
pubmed:articleTitle |
A randomised comparison of increase in serum 25-hydroxyvitamin D concentration after 4 weeks of daily oral intake of 10 microg cholecalciferol from multivitamin tablets or fish oil capsules in healthy young adults.
|
pubmed:affiliation |
Institute of General Practice and Community Medicine, University of Oslo, PO Box 1130 Blindern, N-0318 Oslo, Norway. kristin.holvik@medisin.uio.no
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|